Global burden of pneumoconiosis attributable to occupational particulate matter, gasses, and fumes from 1990∼2021 and forecasting the future trends: a population-based study

被引:1
|
作者
Mao, Qingsong [1 ]
Xiao, Ruijie [2 ]
Yang, Wenqi [2 ]
Wang, Xinyi [2 ]
Kong, Yu-zhe [2 ]
机构
[1] Chongqing Med Univ, Hepatobiliary Pancreat Surg, Banan Hosp, Chongqing, Peoples R China
[2] Cent South Univ, Xiangya Sch Med, Changsha, Peoples R China
关键词
pneumoconiosis; occupational risk; mortality forecasting; epidemiology; disease burden; HUT LUNG; DISEASE; PREVALENCE; WORKERS;
D O I
10.3389/fpubh.2024.1494942
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Background This study aimed to quantify the global impact of pneumoconiosis resulting from occupational exposure to particulate matter, gasses, and fumes from 1990 to 2021, utilizing data from the Global Burden of Disease Study 2021. Method The analysis evaluated the global, regional, and national burden of pneumoconiosis attributable to workplace exposure to particulate matter, gasses, and fumes. It explored variations in disease impact across different demographics, including age and gender, and analyzed the relationship between disease burden and the Socio-Demographic Index (SDI). Furthermore, an ARIMA model was employed to forecast future trends of pneumoconiosis up to 2050. Result The year 2021 saw pneumoconiosis from occupational particulate matter, gasses, and fumes account for roughly 4,775 deaths and 117.80 thousand disability-adjusted life years (DALYs). Over the past three decades, there was a notable decline in the disease's burden. The condition predominantly affected males and those aged above 60. Future projections suggest a decrease in mortality rates in low to middle SDI regions, while high SDI regions may experience an increase in ASMR. Additionally, both ASMR and ASDR are anticipated to rise globally. Nationally, the Czech Republic, France, and the United States are expected to show relatively higher mortality rates in 2030 and 2050. Countries like Kazakhstan, Egypt, Mongolia, and Peru are projected to experience elevated levels of ASMR, DALY rates, and ASDR. Conclusion The findings underscore the urgent need for policymakers to create and improve targeted preventive strategies to reduce the incidence of pneumoconiosis among specific populations.
引用
收藏
页数:12
相关论文
共 50 条
  • [21] Trends in the global, regional, and national burden of bladder cancer from 1990 to 2021: an observational study from the global burden of disease study 2021
    Su, Xingyang
    Tao, Yifang
    Chen, Feng
    Han, Xiujuan
    Xue, Li
    SCIENTIFIC REPORTS, 2025, 15 (01):
  • [22] Burden attributable to risk factors in Mexico, 1990-2021. Summary of findings from the Global Burden of Disease 2021 study
    Razo, Christian
    Morales-Juarez, Linda
    Cagney, Jack
    Rios-Blancas, Maria Jesus
    Montoya, Alejandra
    GACETA MEDICA DE MEXICO, 2023, 159 (06): : 539 - 548
  • [23] Global, regional, and national burden of chronic obstructive pulmonary disease and its attributable risk factors from 1990 to 2021: an analysis for the Global Burden of Disease Study 2021
    Wang, Zhufeng
    Lin, Junfeng
    Liang, Lina
    Huang, Feifei
    Yao, Xiaoyin
    Peng, Kang
    Gao, Yi
    Zheng, Jinping
    RESPIRATORY RESEARCH, 2025, 26 (01)
  • [24] Trends in global ambient fine particulate matter pollution and diabetes mortality rates attributable to it in the 1990-2019: 30 years systematic analysis of global burden of disease
    Ye, Junjun
    Li, Jilin
    Li, Liping
    Zhang, Shuo
    Chen, Jingxian
    Zhu, Dan
    Zhang, Chuanyan
    Xie, Bin
    Zhang, Bangzhou
    Hou, Kaijian
    SCIENCE OF THE TOTAL ENVIRONMENT, 2024, 908
  • [25] The global, regional, and national late-life depression burden and trends from 1990 to 2021: A systematic analysis for the Global Burden of Disease Study 2021
    Sun, Quan
    Wei, Yulong
    Xie, Hongting
    Lyu, Jiaxuan
    Zhou, Jingpei
    Li, Xinyu
    Peng, Wanqing
    Zhao, Renhui
    Li, Ziyuan
    Chen, Zhenhu
    Lyu, Jun
    Wang, Nanbu
    ARCHIVES OF GERONTOLOGY AND GERIATRICS, 2025, 131
  • [26] Global trends in melanoma burden: A comprehensive analysis from the Global Burden of Disease Study, 1990-2021
    Sun, Yulin
    Shen, Yiming
    Liu, Qian
    Zhang, Hao
    Jia, Lingling
    Chai, Yi
    Jiang, Hua
    Wu, Minjuan
    Li, Yufei
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2025, 92 (01) : 100 - 107
  • [27] Global and China trends and forecasts of disease burden for female lung Cancer from 1990 to 2021: a study based on the global burden of disease 2021 database
    Li, Bilu
    Wu, Yuyan
    Zhang, Yanhong
    Hu, Chengyun
    Li, Xue
    Luo, Shanshan
    Sun, Chenyu
    Yousef, Iyad
    Wang, Yefei
    Tang, Chaoliang
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2025, 151 (02)
  • [28] Global, regional, and national drowning trends from 1990 to 2021: Results from the 2021 Global Burden of Disease Study
    Zhu, Weimin
    He, Xiaxia
    San, Renfei
    Chen, Nanjin
    Han, Tingfen
    Zhang, Sheng
    Xu, Yubin
    Jin, Shengwei
    Xu, Yinghe
    Jiang, Yongpo
    ACADEMIC EMERGENCY MEDICINE, 2024, : 1212 - 1222
  • [29] Trends in the burden of epilepsy in China from 1990 to 2021 and its forecast until 2044: based on the 2021 Global Burden of Disease study
    Fang, Zhiyong
    Wang, Feng
    Mei, Zhen
    Huang, Xiaofen
    Gao, Lin
    Zheng, Lixian
    Lin, Yuanxiang
    Hu, Xuequn
    QJM-AN INTERNATIONAL JOURNAL OF MEDICINE, 2025,
  • [30] Global Burden and Trends in Acute Myeloid Leukemia in the European Union From 1990 to 2021: Insights from the Global Burden of Disease Study, 2021
    Patel, Dharmik
    Gupta, Manvi
    Suppala, Praveena
    Hara, Mankarn Singh
    Daid, Simran Preet Singh
    Munnangi, Pragathi
    Hirpara, Ishita
    Sharma, Akhilesh
    Saleh, Abobakr
    Patel, Vishwesh
    Katikala, Ramana
    Desai, Hardik
    Koduru, Tanvi
    Muddassir, Salman
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2024, 24 : S337 - S337